Bristol-Myers Squibb shares rise 3.8% in premarket trading following reports of deal discussions with AstraZeneca.
FirstSquawk08/03, 03:07 PM
Related assets
Coming up for BMY
Explore next
Latest BMY news
Jin1008/05, 07:04 PM
Astrazeneca and Bristol Myers Squibb have no ongoing discussions regarding a potential transaction.
Finnhub08/04, 12:17 AM
Finnhub08/03, 10:50 PM